Eric Lindenfeld Joins Robins Kaplan's Mass Tort Group

Robins Kaplan LLP recently welcomed Eric Lindenfeld to the firm’s Mass Tort Group, where he focuses his practice on representing individuals who have been harmed by defective pharmaceutical and medical device products. Lindenfeld has experience in all phases of mass tort litigation, including trial practice, motion practice, conducting depositions, and written discovery. He is admitted to practice in Minnesota and in the U.S. District Court, District of Minnesota.

Lindenfeld earned his law degree, with honors, from the University of Minnesota. While attending law school, he won awards for outstanding written advocacy in various moot court competitions. He has also authored several scholarly articles on cutting-edge and developing topics in mass tort litigation.

Lindenfeld’s publications have been widely cited by law professors and practitioners, including in the Law, Medicine & Medical Technology and the Food and Drug Administration casebooks.